Expression of the Saccharomyces cerevisiae CLN1 and CLN2 genes is cell cycle regulated, and the genes may be controlled by positive feedback. It has been proposed that positive feedback operates via Cln/Cdc28 activation of the Swi4/Swi6 transcription factor, leading to CLN1 and CLN2 transcription due to Swi4 binding to specific sites (SCBs) in the CLNI and CLN2 promoters. To test this proposal, we have examined the effects of deletion either of the potential SCBs in the CLN2 promoter or of the SWI4 gene on CLN2 transcriptional control. Deletion of a restriction fragment containing the identified SCBs from the promoter does not prevent cell cycle regulation of CLN2 expression, although expression is lowered at all cell cycle positions. A promoter containing a 5.5-kb plasmid insertion or an independent 2.5-kb insertion at the point of deletion of the SCB-containing restriction fragment also exhibits cell cycle regulation, so involvement of unidentified upstream SCBs is unlikely. Neither Swi4 nor the related Mbpl transcription factor is required for cell cycle regulation of the intact CLN2 promoter. In contrast, Swi4 (but not Mbpl) is required for correct cell cycle regulation of the insertion/deletion promoter lacking SCB sites. We have extended previous genetic evidence for involvement of Swi4 in some aspect of CLN2 function: a mutant hunt for CLN2 positive regulatory factors yielded only swi4 mutations at saturation. Swi4 may bind to nonconsensus sequences in the CLN2 promoter (possibly in addition to consensus sites), or it may act indirectly to regulate CLN2 expression.
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Start in the budding yeast cell cycle is the time in late G1 at which cells become committed to cell cycle progression (29) . Start is controlled by the Cdc28 protein kinase, which is activated at Start by the G1-acting cyclin homologs Clnl, Cln2, and Cln3 (23, 30) . Clnl and Cln2 are cyclically expressed in the cell cycle; transcript and protein levels peak around the time of Start (34, 36) . Cln3 levels vary little in the cell cycle (34, 35) .
The strong increase in CLN1 and CLN2 transcription around the time of Start requires the activity of Cdc28 and at least one of the three Cln proteins (9, 11) , suggesting that a positive feedback loop may control their transcription.
The Swi4/Swi6 transcription factor activates transcription of the HO endonuclease gene at Start (1, 6, 16, 22, 25) . Swi4 and Swi6 are components of a complex that binds to a consensus sequence (SCB) repeated 10 times in the HO promoter (1, 21, 28) . The SCB sequence is sufficient to confer cell cycleregulated expression (6) . Swi4 is the DNA-binding component of the Swi4/Swi6 complex, and Swi6 binds to Swi4 (28) . It was proposed that Swi4/Swi6 regulates CLNJ and CLN2 transcription (24, 26) : there are SCB consensus sequences in the CLN1 and CLN2 promoters, and genetic interactions between SWI4, SWI6, CLN1, CLN2, and CLN3 were observed. Swi4/Swi6 complexes bind specifically to these sequences from the CLN2 promoter in vitro (24, 26) . Reductions in CLN1 and CLN2 RNA levels were observed in swi4 mutant strains (24, 26) .
The Mbpl protein is related to Swi4 (18) ; it interacts with Swi6 to make the DSC1/MBF transcription factor (10, (18) (19) (20) , which functions to regulate transcription of genes involved in DNA synthesis, by binding to the MCB consensus; the MCB site is sufficient to confer cell cycle-regulated expression. It was proposed that Swi4 and Mbpl might cooperate in regulating CLNJ and CLN2 transcription (18) .
We report analysis of the requirement for Swi4-binding sites, Mbpl, and Swi4 for regulating CLN2 transcription.
MATERIALS AND METHODS
Plasmid constructions. Standard methods were used throughout (2). JM206 contained cin2-deIxs (9) sequences from 1.2 kb 5' to the initiation codon to the HindIll site at position 1852 (9, 14) , cloned in RS306 (Sall to Hindll) (33) . The Sall site was from the pBR322-based cloning vector in which CLN2 was initially isolated (15 Yeast strains and introduction of promoter mutations. All strains were isogenic with BF264-15D. clnl-del, cln2-delxs, cln3-del, and the GAL1::CLN3 and GALl::CLNJ expression cassettes were all described previously (8, 9, 30) . The swi4::LEU2 construct replaced the internal BamHI fragment of SWI4 with LEU2; this construct was provided by B. Andrews and was introduced into the BF264-15D background by one-step gene replacement (29a). The swi4::LEU2 allele was initially introduced into a clnl cln2-delxs cln3 pGALl::CLN3 background; while such strains were viable, they were slow growing and highly abnormal morphologically; it also proved difficult to synchronize these strains (29a). Therefore, the swi4::LEU2 allele was backcrossed three times into an isogenic cmnI cln2 cln3 pGAL1::CLNJ background; GALJ::CLNJ completely rescued the growth rate and partially rescued cell morphology and synchronizability of swi4::LEU2 strains (data not shown). Backcrossed swi4::LEU2 strains were compared with isogenic SW!4 siblings from the same backcross. The mbpl::URA3 construct (18) replaced an internal EcoRI fragment of MBPJ with URA3.
The cln2::URA3 allele was introduced by one-step gene disruption in a strain (1315-23D) of genotype clnl-del CLN2 cln3-del leu2::LEU2::GAL1::CLN3. Ura' transformants in which cln2 was disrupted became galactose dependent for viability. One such strain, 1315-23Db, was chosen for further work. The wild-type cln2 promoter, the cln2-delNS promoter, and the cln2-delNS/SCB promoters were introduced into 1315-23Db by cotransformation of linear fragments containing the mutant promoters driving the cln2-delxs nonfunctional coding sequence and a TRP1 episomal vector. Trp+ transformants were tested on 5-FOA to identify Ura-derivatives. On blot hybridization, these Ura-derivatives all proved to contain the indicated promoter driving the cln2-deLxs coding sequence.
The TATA deletion constructs in JM217, MH206-9, and MH206-10 and the YRp7-substituted promoters in FC206-6, FC206-8, and FC206-1 were introduced by duplicative integration by digestion of the plasmids with BclI (cutting in the cln2-debcs coding region) and transformation of ura3 clnl-del cln2-deLbs cln3-del leu2::LEU2::GALJ::CLN3 yeast to Ura+. Following integrative duplication, popouts were selected on 5-FOA and screened by Southern blot hybridization to identify yeast strains in which the mutant promoter had replaced the wild type.
Strain 1531-8B (clnl-del cln2::URA3 cln3-del leu2::LEU2:: GAL1::CLN3 his3 HIS2) was constructed by mating and tetrad analysis. This strain was transformed with XhoI-and EcoRIdigested FC206-14, and His+ transformants were selected.
Transformations in which cln2-delNSIHIS3IkanR had replaced cln2::URA3 were identified by a Ura-phenotype.
Cell cycle synchronization. clnI cln2 cln3 GAL1::CLN3 strains were synchronized in G. by incubation in raffinose and released into synchronous cell cycles by galactose addition, as described elsewhere (9) .
DNA and RNA analysis. DNA and RNA extraction and analysis were as described elsewhere (2, 9, 17) .
Mutant hunt. A strain of genotype clnI CLN2 cln3 pURA3/GAL1::CLN3 was mutagenized with ethyl methanesulfonate as described elsewhere (32) and plated on yeast extractpeptone-galactose plates at 100 to 200 colonies per plate. When colonies were grown, they were replica plated to yeast extract-peptone-dextrose medium, and colonies unable to propagate on glucose medium at 38°C were identified. Those strains that were unable to propagate solely because of inviability on glucose (unrelated to expression of GALJ::CLN3)
were identified by their ability to grow on 5-fluoro-orotic acid plus galactose medium (4) and discarded. We established a quantitative criterion for tightness of these mutants: less than 1 viable colony on glucose medium per 104 viable colonies on galactose medium. This criterion was important in excluding a large number of leaky mutants. Mutants were mated to the wild type, and 2:2 segregation of the mutant phenotype was established (32) . This procedure also generated complementation testers for the mutants. The mutant hunt was carried out at 38°C in the hope of identifying temperature-sensitive alleles of the complementation groups. No tight temperature-sensitive alleles were recovered; however, we observed that the swi4 alleles recovered (see below) were generally leakier at 30°C than at 38°C. (24, 26) was deleted in cln2-delNS (second line). In cln2-delNS/3XSCB (third line), three synthetic SCB sequences were inserted at the point of this deletion. These promoters were substituted for the wild-type promoter, driving the defective reporter cln2 coding sequence from the cln2-delxs allele (9) . (B) Four independently derived clones with either the wild-type promoter, the cln2-delNS promoter, or the cln2-delNS/3XSCB promoter were tested for cln2 RNA levels in asynchronous culture. Pr-, protein 1 mRNA; HZ4, histone H2A mRNA. Strains were isogenic and were clii cln2-delrs chn3 GALI::CLN3. (C) clnl cln2-delxs chn3 GALJ::CLN3 strains were blocked in GI by incubation in raffinose medium and then released into synchronous cell cycles by addition of galactose (9) . In this experiment, one strain (1315-23D-1, lower panels) contained the wild-type chn2 promoter, and the other (1315-23D-2, upper panels) contained the cln2-delNS promoter. These strains were isogenic. Samples were extracted every 12 min. RNA blots were probed with cln2 probe or with a probe detecting both protein 1 (Prl) and histone H2A mRNA (27) . The former is cell cycle constitutive and serves as a loading control; the latter is highly expressed in S phase. In all experiments reported here, the first and second cycles of bud emergence corresponded roughly with the rise in histone H2A mRNA levels (data not shown). (D) The experiment was performed exactly as in C, except that a strain containing chn2-delNS/3XSCB was used.
RESULTS
Deletion of Swi4-binding sites. Three potential SCB elements were identified in the CLN2 promoter (24, 26, 28) , within a 101-bp NruI-SphI restriction fragment (14) (Fig. 1) . We deleted this fragment from the chromosome, producing the cln2-delNS allele (Fig. 1) . We did this in a clnl-del cln2-delxs cln3-del GAL1::CLN3 or GALJ::CLN1 background, in order to assay CLN-dependent chn2 transcription (the nonfunctional cln2-delxs coding sequence contains a deletion in the cyclin homology region but produces a properly regulated transcript [9] ). The deletion resulted in a strong defect in CLN2 transcription in asynchronous culture (Fig. 1) . Introduction of three tandem SCB sequences (6) in place of the deleted fragment restored a high level of cln2 expression (Fig. 1) , consistent with the idea that low expression from the cln2-deiNS promoter was due to loss of SCB elements from the promoter.
Surprisingly, cln2 expression from the chn2-delNS promoter is cell cycle regulated, with timing similar to that of the wild type (Fig. 1) . cln2 expression from the synthetic SCB-containing promoter was also cell cycle regulated (Fig. 1 ), at a much higher level of expression.
Cell cycle regulation of chn2 transcription from the promoter with the SCBs deleted could be due to additional unidentified SCB elements farther upstream than the regions sequenced (14, 24) . To attempt to insulate the cln2-delNS promoter from potential upstream regulatory sequences, we inserted most of the YRp7 plasmid (a 5.5-kb pBR322 derivative containing TRPJ [2] ) in the chromosome in place of the 101-bp NruI-SphI fragment containing the identified SCBs (chn2-delNS/YRp7 [ Fig. 2] ). This deletion/insertion would place any unidentified upstream SCB elements 5.5 kb farther upstream from the cln2 transcriptional start site than they are in the wild-type promoter. This promoter directs cell cycle-regulated cln2 expression (Fig. 2) . RNA from this promoter was correctly initiated, as shown by primer extension analysis (data not shown). We constructed a promoter in which YRp7 was inserted in the same position as in cln2-delNS/YRp7 but in the opposite orientation (Fig. 2) . Cell cycle regulation of cln2 expression was observed with this promoter as well, although this promoter showed less of a drop in cln2 RNA levels late in the cell cycle (Fig. 2D) .
We recombined these deletion/insertion promoters with the intact CLN2 coding sequence and examined the function of the mutant gene. CLN2-delNS/YRp7 and CLN2-delNS/YRp7B resulted in complete viability in a clnI chn3 background; cell volume (a sensitive indicator of CLN gene function [7, 15, 34] ) was similar in these strains to that in clin CLN2 chn3 controls (data not shown).
We were concerned that sequences present in YRp7 might have an unanticipated impact on CLN2 regulation. Therefore, we constructed a chn2 promoter with an HIS3/kanR cassette inserted in place of the NruI-SphI fragment. This 2.5-kb insertion has no DNA sequences in common with YRp7. The chn2-delNS/HIS3-kanR promoter showed significant cell cycle regulation, albeit at a low level of expression (Fig. 2C) . Thus, although the different insertions have subtly different properties, cell cycle regulation of CLN2 is observed with all three.
In these constructs, YRp7 or HIS3/kanR is inserted between positions -601 and -500 (Fig. 2) . There are no sequences matching the SCB consensus (24, 26) between -500 and the initiation site (14) . Therefore, it appears unlikely that any SCB sequences are required for cell cycle control of CLN2 transcription, although sequences in the SCB-containing -600 to -501 restriction fragment clearly contribute strongly to the overall level of CLN2 expression. Thus, there is probably another element in the minimal -500 promoter that is (Fig. 3A) . This element might still provide cell cycle control if the control were redundant with control from the SCB sequences. Therefore, we combined the deletion of this sequence with the deletion/insertion of YRp7 described above. Effective regulation of these double-mutant promoters, with timing similar to that of the wild type, was observed ( Fig. 3) , despite the abnormality of electrophoretic mobility of cln2 transcripts produced. For [28] ). We observed significant cell cycle regulation of cln2 RNA in swi4::LEU2 strains (Fig. 4) . This was true despite an overall reduction in cell cycle synchrony in the swi4::LEU2 strain, as indicated by the histone H2A control for degree of cell cycle synchrony (Fig. 4) and by decreased synchrony of bud emergence in swi4::LEU2 strains compared with SWI4 controls (data not shown)
.
Surprisingly, when we tested the cln2-delNS/YRp7 construct in a swi4::LEU2 strain, we found that deletion of SWI4 largely eliminated cell cycle regulation of this promoter in the first cell cycle following release (Fig. 4B) . This result was unanticipated, since this promoter mutation was designed to eliminate Swi4-binding sites. The relevance of this observation to control of CLN2 transcription from the intact promoter by Swi4 is unclear.
The delayed rise in CLN2 transcription observed in the swi4::LEU2 cln2-delNS/YRp7 strain in this experiment was reproducible (three strains tested). We do not have an explanation for this at present.
Cell cycle regulation of CLN2 in the absence of Mbpl. The Mbpl transcription factor is related to Swi4 and has been proposed to cooperate with Swi4 in CLN2 regulation (18) . We tested mbpl::URA3 strains for regulation of transcription of CLN2 either from the intact promoter or from the delNS/YRp7 promoter. The mbpl::URA3 strains showed regulation similar to that of the MBP1 strains (Fig. 5) . Thus, at least in SWI4 strains, Mbpl is not required for CLN2 regulation. However, it may be required in the absence of Swi4 (18) . CLNJ cell cycle regulation was shown to be normal in mbpl strains (18) .
A mutant hunt for factors essential for CLN2 function. clnl CLN2 cln3 strains, but not clnl CLN2 CLN3 strains, were inviable in the absence of SWI4 (24) , supporting the idea (24, 26) that Swi4 might be an essential activator of CLN2. To ask whether there were other genes that could mutate to give this phenotype, we mutagenized a strain of genotype cmni CLN2 cln3 GAL1::CLN3 and identified 34 mutants that were inviable when GALi::CLN3 was turned off by a switch from galactose to glucose (see Materials and Methods).
Seven mutations fell into the ercl complementation group. ercl mutants exhibited no detectable defect in CLN2 expression, nor did they display a cell cycle-specific arrest, but rather lysed after multiple cell cycles on glucose medium (data not shown). ercl mutations also result in lethality in clni cln2 CLN3 strains (data not shown). Thus, Ercl is probably not specifically involved in CLN2 function.
We isolated 27 mutants that gave a GI arrest phenotype.
Fourteen of these were in the cln2 gene itself. The remaining 13 mutants were all in the same complementation group (erc2), which we identified as swi4: (i) erc2-1 failed to complement swi4::LEU2 and failed to recombine with swi4::LEU2 in meiotic analysis; and (ii) a low-copy-number plasmid that complemented erc2-1 contained SWI4 on the basis of partial sequence analysis, and rescuing activity mapped to the SWI4 region of the plasmid; the insert in this plasmid was shown to map to the erc2-1 locus (data not shown).
An erc2-1 (swi4) clnl CLN2 cln3 GALJ::CLN3 strain gave first-cycle arrest as unbudded GI cells upon shift to glucose ( Fig. 6B and data not shown). clni CLN2 cln3 erc2-1
GALi::CLN3 strains transformed with CLNJ on a low-copynumber plasmid were essentially inviable on glucose medium (data not shown), consistent with the idea that Swi4 is required for efficient CLNJ expression (24, 26) . erc2-1 clnl cln2 CLN3 strains were viable (data not shown), further confirming the specificity of this mutation to CLNJ and CLN2 function (however, swi4 null mutations result in lethality in a clnl cln2 CLN3 background [24] ).
Since this mutant hunt was carried to saturation (7 ercl mutations, 13 swi4 mutations, and 14 cln2 mutations, with all mutants accounted for), there are probably few or no other genes that are essential for viability in a clni CLN2 cln3 GAL1::CLN3 strain on glucose but are not essential on galactose. This result increases the specificity of the conclusion that SWI4 is required for solo function of CLN2 (24) . swi6 deletion is nearly lethal even on galactose medium in such a strain (data not shown) (24) , so mutations in this gene could not have been recovered.
We observed a deficit in CLN2 expression in erc2 mutant strains when GALI::CLN3 was off (in glucose medium), but not when GALJ::CLN3 was on (in galactose medium) (Fig.  6A) . Thus, a defect in CLN2 expression correlated with the erc2 mutant phenotype and, intriguingly, was efficiently rescued by GAL1::CLN3 in the erc2 mutant strains. This result is consistent with the proposal (34) that CLN3 is an efficient transcriptional activator of CLN1 and CLN2.
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DISCUSSION
Swi4 and the control of CLN2 expression. These experiments were carried out as a test of the proposal (24, 26) that Swi4 binding to SCBs in the CLN2 promoter was responsible for cell cycle regulation of CLN2 expression. The results obtained present difficulties for this proposal: (i) deletion of a fragment containing the identified SCBs lowered expression overall but had little effect on cell cycle control, (ii) deletion of these sequences combined with insertion of either a 5.5-kb insertion (YRp7) or a 2.5-kb insertion (HIS3/kanR) at the site of deletion (to increase the distance between the CLN2 promoter and hypothetical SCBs farther upstream) also had little effect on cell cycle regulation, and (iii) deletion of Swi4 had little effect on cell cycle regulation of CLN2.
However, other results support the proposed involvement (24, 26) of Swi4 in CLN2 regulation. Deletion of a fragment containing the identified SCBs strongly reduced cln2 expression (Fig. 1) . Deletion of SWI4 nearly eliminated cell cycle regulation of a minimal CLN2 promoter (Fig. 5) . Also, a mutant hunt for essential factors specific for CLN2 function turned up only swi4 mutations at saturation; these mutations resulted in defects in CLN2 expression (Fig. 6A) (Fig. 2A) . Abbreviations are as for Fig. 1 .
under conditions where expression of CLN genes is low. Thus, Swi4 might be required for attaining an initial minimum level of expression of CLNJ and CLN2, but once sufficient CLN expression occurs, other CLN-dependent mechanisms might be able to drive CLNJ and CLN2 expression. In the experiments presented here, cell cycle progression is being driven by CLN overexpression from the strong GALl promoter; this might eliminate an Swi4 requirement for CLN2 expression, which would be revealed when the GAL1::CLN gene was turned off (Fig. 6) .
The mode of involvement of Swi4 in the control of CLN2 expression is not entirely clear. Neither Swi4 nor its proposed binding sites in the CLN2 promoter are required for CLN2 regulation. While genetic results (references 24 (Fig. 4) , and this truncated promoter contains no recognizable consensus binding sites for Swi4 (14, 24, 26 (Fig. 2A) . Abbreviations are as for Fig. 1 (A) Strains were grown in synthetic medium lacking uracil, at 380C. The strains were shifted to glucose medium for the indicated number of hours, and the levels of CLN2 transcript were analyzed. The levels of TCMI transcript (31) were analyzed as a control. All strains were cmni cln3 pURA3-GALJ::CLN3. Lanes: 1, CLN2 SWI4; 2, cln2-delxs SWI4; 3, CLN2 erc2-1 (swi4); 4, CLN2 erc2-1 (swi4); 5, CLN2 erc2-2 (swi4); 6, CLN2 erc2-3 (swi4). (B) All strains were cmni cln3 trpi::TRPJ::GALJ::CLN3. Strains were CLN2 SWI4, CLN2 erc2-1 (swi4), cln2 SWI4, or cln2 erc2-1 (swi4), as indicated. Log-phase cultures grown at 30'C in yeast extract-peptone-galactose were shifted to yeast extract-peptone-dextrose, and at intervals the percentage of unbudded cells (indicative of pre-Start G, [29] ) was determined.
is dependent on SWL6 (12) , however, which differs from the lack of strong dependence of CLN2 periodicity on SfW4 (Fig. 4) .
Mbpl and the control of CLN2 expression. The DSC1/MBF transcription factor, composed of Mbpl and Swi6, acts through a binding site called MCB to regulate a class of genes involved in DNA replication (10, (18) (19) (20) . Mbpl is a relative of Swi4, and Swi4 and Mbpl were proposed to cooperate in regulation of CLN2 (18) ; this hypothesis could explain cell cycle regulation of CLN2 in the absence of Swi4 (Fig. 4) . However, cell cycle regulation of the intact CLN2 promoter and the minimal cln2-delNSIYRp7 promoter was normal in the absence of MBPJ (Fig. 5 ). Mbp1 and Swi4 bind to moderately related sequence elements, and their respective optimal binding sites crosscompete (10, 18) . However, there are no matches to either the Mbpl-or the Swi4-binding sites or to a proposed hybrid consensus sequence (C-CG--A) (18) in the minimal cln2-delNS/YRp7 promoter (between -500 and the transcription start site at -174) ( Fig. 1) (14) .
Genetic results (24, 26) led to the proposal that Swi6 was involved together with Swi4 in regulation of CLNI and CLN2. However, two recent reports demonstrated near-normal regulation of CLN2 in swi6 null strains (10, 19) although CLN1 was moderately (19) or strongly (10) deregulated in such strains. This result is relevant to the question of Mbpl overlap with Swi4 (18) . Since Swi6 is thought to interact both with Swi4 (in the SBF transcription factor) and with Mbpl (in the DSC1/ MBF transcription factor), deletion of Swi6 might be expected to inactivate both factors; and yet CLN2 is still cell cycle regulated in the absence of Swi6 (10, 19) .
